验证格鲁吉亚的COVID-19疫苗注册表2023-2024赛季:真正的GRITS
Allison D Roebling1, Nathaniel Elijah Barrera-Nitz1, Melissa Tobin-D'Angelo1
1Allison D. Roebling, Nathaniel Elijah Barrera-Nitz, Kyle P. Openo, and Lucy S. Witt are with the Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, and the Georgia Emerging Infections Program, Atlanta. Melissa Tobin-D'Angelo is with the Georgia Department of Public Health, Atlanta, GA.
American journal of public health
|February 11, 2026
概括
乔治亚 乔治亚 乔治亚 乔治亚 乔治亚
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 免疫系统 免疫系统
背景情况:
- 准确的COVID-19疫苗报告对于公共卫生监测至关重要.
- 格鲁吉亚疫苗接种交易和服务注册表 (GRITS) 是该州的免疫信息系统.
- 评估GRITS的完整性对于了解疫苗覆盖率至关重要.
研究的目的:
- 评估医疗保健提供者向GRITS报告COVID-19疫苗的完整性.
- 为了评估2023年10月1日至2023年12月31日期间在首都亚特兰大住院的COVID-19患者的数据准确性.
主要方法:
- 活动,人口和实验室监测在亚特兰大8个大都市县确定了COVID-19住院病例.
- 一组患者被随机抽取样本,进行详细的图表审查.
- 与患者,代理人,药房和医生进行的电话随访验证了疫苗接种状态,并确定了未记录的剂量.
主要成果:
- 在研究期间,有2165例COVID-19住院病例发生.
- 随访发现只有1个COVID-19疫苗剂量未在注册表中记录.
- 广泛的后续工作带来了极少的额外疫苗接种数据.
结论:
- 格里茨注册表显示,在亚特兰大大区住院患者中,COVID-19疫苗接种情况的完整性很高.
- 该注册表是该人口免疫数据的可靠来源.
- 进一步的密集后续行动不太可能显著改善数据的完整性.
相关概念视频
Vaccinations
44.1K
Overview
44.1K
Bioequivalence studies: Biowaivers
430
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
430
Glucagon-like Receptor Agonists
1.3K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K
Vaccine Production
144
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
144
Vaccines
98
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
98
Influenza
87
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
87


